TheMarker

TheMarker provides a curated database of therapeutic biomarkers (ThMAR) to support identification, classification, and application of pharmacodynamic, safety, monitoring, predictive biomarkers and surrogate endpoints across drug development, clinical management, and regulatory evaluation.

Key Features:

• Focus on therapeutic biomarkers (ThMAR): Emphasizes therapeutic biomarkers distinct from diagnostic and prognostic biomarkers.
• Types of Therapeutic Biomarkers: Systematically categorizes five ThMAR types—pharmacodynamic biomarkers, safety biomarkers, monitoring biomarkers, predictive biomarkers, and surrogate endpoints.
• Comprehensive Coverage: Catalogs therapeutic biomarkers across a wide range of drugs and diverse disease classes, extending beyond anticancer therapies.
• Systematic Organization: Organizes biomarker data to support stages of drug development from discovery through clinical application.

Scientific Applications:

• Drug Discovery and Development: Supports identification of biomarkers relevant to drug efficacy and safety and selection of patient-specific therapeutic strategies.
• Clinical Practice Enhancement: Enables tailoring of treatment using predictive biomarkers, monitoring therapy progress with monitoring biomarkers, and assessing adverse effects with safety biomarkers.
• Regulatory Evaluation: Provides surrogate endpoint information to inform regulatory assessment and expedite therapy approval processes.

Methodology:

Systematic compilation and curation of therapeutic biomarker information across drug classes and disease categories.